MedTrace Logo

Translating the ABCS Into HIV Care

NCT03902431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4277

Last updated 2024-09-19

No results posted yet for this study

Summary

The overall objective of this project is to develop and rigorously test implementation strategies to address the gap in scientific knowledge of lower use of evidence-based interventions commonly referred to as the ABCS (aspirin, blood pressure control, cholesterol control, and smoking cessation)which contributes to the growing CVD morbidity and mortality among PLH.

Conditions

  • HIV
  • Cardiovascular Risk Factor

Interventions

BEHAVIORAL

ABCS training

Clinicians and patients will be given information regarding the ABCS (Aspirin, Blood Pressure control,Cholesterol control, and Smoking Cessation) and for reducing CVD risk among HIV patients.

Sponsors & Collaborators

  • Clinical Directors Network

    collaborator NETWORK

  • University of Texas

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Rochester

    lead OTHER

Principal Investigators

  • Kevin Fiscella, MD, MPH · University of Rochester

  • Jonathan Tobin, PhD · Clinical Directors Network, Inc; Albert Einstein College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-26
Primary Completion
2022-08-31
Completion
2024-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03902431 on ClinicalTrials.gov